Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1989;238(5-6):231-9.
doi: 10.1007/BF00449803.

New perspectives on the molecular pharmacology of affective disorders

Affiliations
Review

New perspectives on the molecular pharmacology of affective disorders

F Sulser. Eur Arch Psychiatry Neurol Sci. 1989.

Abstract

Research with antidepressants has emphasized the importance of a delayed deamplification of the linked serotonin (5HT)/norepinephrine (NE) receptor coupled adenylate cyclase system in brain. The basic phenomena of regulation of receptor number and function of the beta adrenoceptor linked adenylate cyclase system in brain are well established, with NE regulating beta adrenoceptors in the high agonist affinity conformation (linked to adenylate cyclase and down-regulated by antidepressants), and with 5HT regulating those receptors in the low agonist affinity conformation. The biochemical effector systems of NE and 5HT are discussed and it is concluded that the final common pathway of signal transduction is protein kinase mediated phosphorylation of cellular proteins. Glucocorticoid receptors are located in the perikarya of aminergic cell bodies and may exert their effects by modifying the genomic expression of the diffusely projecting stress-responsive monoamine systems. The molecular neurobiology of beta adrenoceptors, with its implication for genetic and immunologic investigations, is briefly discussed and further research on stimulus-transcription coupling and regulation of gene expression in brain is suggested as an exciting new direction in central receptor research relevant to the psychopharmacology of affective and other disorders.

PubMed Disclaimer

References

    1. J Neurosci. 1986 Dec;6(12):3669-75 - PubMed
    1. J Pharmacol Exp Ther. 1985 May;233(2):473-9 - PubMed
    1. J Pharmacol Exp Ther. 1987 Apr;241(1):251-7 - PubMed
    1. J Histochem Cytochem. 1975 Jan;23(1):1-12 - PubMed
    1. J Pharmacol Exp Ther. 1983 Jul;226(1):71-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources